Biotechnology Companies in Middle East

Nanomik, develops & produces microencapsulated biopesticides for food and agricultural products that protects them against food spoilage without changing their quality. Today whole World suffers from the food waste. Approximately 30% of fresh fruits and vegetables are lost before coming to the stall. Economic impact of mentioned losses is beyond 1.3 Billion $ annually. In traditional preservation, very harmful chemicals and their synthetic derivatives are used for protection; however, their usage is limited because of their negative effects to the human. Amounts allowed for usage are not sufficient for the long-term protection. These chemicals and harmful microorganism toxins are the main problems for the export of agricultural products because of their harmful effects to human and nature. Our company Nanomik aims to show that all food and agricultural products can be protected naturally without harmful chemicals and food waste can be decreased to the minimal levels. Mainly, the World with more natural products and healthy foods is aimed by Nanomik!

Our immersive platform helps people understand the relationship between their cognitions, emotions, and actions and utilize the influence that one exerts on the other. With a data-driven algorithm combined with virtual reality technology, we continuously track user behavior over the course of their health-activating journey and generate the most personalized program to enhance their mental, physio-physical, or social and emotional skills.

Wilk is at the forefront of cell-grown milk production, developing solutions that answer the long-term needs of the milk markets.

CBX Therapeutics is a California-based biotechnology company focused on developing innovative, cannabinoid-based solutions for neurological and neurodegenerative disorders.

We are dedicated to providing immediate relief for patients suffering from Parkinson’s disease, primarily through our fast-acting oral disintegrating tablet, TPP-1, and are simultaneously advancing research into broader neuroprotection.

CBX Therapeutics distinguishes itself through a rigorous, translational approach, combining scientific precision with a commitment to real-world clinical relevance. Our platform, CLARIFY, utilizes combinatorial discovery, predictive modeling, and a lean execution framework to accelerate the development of targeted therapies. We welcome collaboration with clinical sites, distribution partners, and wellness brands who share our dedication to scientific integrity and patient-centered outcomes.

Theranica brings electrical neuromodulation therapy to a new level. We have developed Nerivio, a fully-integrated and self-contained family of therapeutic devices suited to be worn everywhere and at any time. The devices are operated by an attractive and easy-to-use smartphone application. We envision a world in which every person has access to smart and affordable, friendly and intuitive, non-invasive and non-pharmacological medical therapy wearables. We believe everyone deserves an enhanced quality of life without hassle or side effects. Millions of people around the world, which will soon be using wearables based on our technology, will experience an improvement to their quality of life, starting with controlling their pain and getting relief in a smart, personal manner, ultimately reducing the use of pharmaceuticals and their side effects. We combine electrical neuro-stimulation (ENS) and Neuromuscular-stimulation (NMES/EMS) technologies with modern wireless communications and smartphone applications. With these advanced technologies, we design and provide products with effective therapy treatments for a variety of severe and widely common medical problems that dramatically degrade our well-being or even endanger life. All of our wearables are easy-to-use, non-invasive, safe, non-chemical, free of side effects*, and will be available at extremely affordable prices. Some of them include proprietary monitoring and reporting attributes, providing key parameters & indicators to the treatment’s efficiency level. As a result of our unique technology, our products present revolutionary pain-alleviating solutions. In addition, our innovative approach for use-and-dispose allows the users to apply and replace the products according to their needs and still keep the personalized programs they created for future use.

RS Research is a clinical stage biotechnology start-up discovering and developing smart nanomedicines. based on innovative drug delivery platform Sagitta® for targeted chemotherapy. Bringing together the powers of science and industry, we have developed a drug delivery technology that will help patients fighting against cancer with superior therapeutic index, “a Cure With a Smile”. Our proprietary drug delivery platform SagittaTM allows designing targeted drug candidates for different indications, which yields into development of our current own portfolio as well as an outstanding co-development potential.